Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With DementiaNCT05276830BioXcel Therapeutics IncPhase 2Terminated2022-04-01Actual
ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)NCT05279417ACRSPhase 2Completed2023-09-05Actual
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable TumorsNCT05280314IO BiotechPhase 2Recruiting2025-04-30Estimated
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)NCT05281471Genelux CorporationPhase 3Recruiting2026-12Estimated
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB1 Antagonist ANEB-001 in a THC Challenge TestNCT05282797Anebulo PharmaceuticalsPhase 2Completed2023-08-26Actual
Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic SeizuresNCT05288283Jazz PharmaceuticalsPhase 3Terminated2023-09-28Actual
A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.NCT05288504AVTXPhase 2Completed2023-05-11Actual
Voclosporin in Adolescent and Pediatric Subjects With Lupus NephritisNCT05288855AUPHPhase 3Terminated2025-07-03Actual
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)NCT05291091EWTXPhase 2Completed2026-09-07Actual
Efficacy and Safety of ALT-801 in the Treatment of ObesityNCT05295875ALTPhase 2Completed2023-09-28Actual
A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.NCT05296629Journey Medical CorporationPhase 3Completed2023-06-30Actual
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older AdultsNCT05297578PCVXPhase 2Completed2023-02-15Actual
A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid MalignanciesNCT05301517Kyntra BioPhase 3Completed2023-04-03Actual
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderNCT05303064Alkermes, Inc.Phase 3Recruiting2026-09Estimated
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)NCT05303519NUVBPhase 3Recruiting2028-12-01Estimated
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)NCT05306574Vor BiopharmaPhase 3Terminated2025-01-06Actual
Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPPNCT05308472IRONPhase 2Completed2024-02-20Actual
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderNCT05312151COMPASS PathwaysPhase 2Completed2024-02-12Actual
Long-term Extension Study of Setrusumab in Adults With Type I, III, or IV Osteogenesis ImperfectaNCT05312697RAREPhase 2Terminated2022-07-07Actual
A Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled HypertensionNCT05314439IONSPhase 2Completed2023-01-31Actual
Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular CarcinomaNCT05317819Polaris GroupPhase 3Recruiting2028-09Estimated
A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive ImpairmentNCT05318937SUPNPhase 2Completed2024-01-17Actual
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of InflammationNCT05318976INMBPhase 2Completed2025-05-12Actual
Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar LinesNCT05320393EOLSPhase 2Completed2023-05-22Actual
Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis SuppurativaNCT05322473MoonLake Immunotherapeutics AGPhase 2Completed2023-05-09Actual
Study of Epetraborole in Patients With Treatment-refractory MAC Lung DiseaseNCT05327803ANTXPhase 2, Phase 3Terminated2024-12-18Actual
Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (R/R) Diffuse Large-cell B-cell Lymphoma (DLBCL)NCT05328102XNCRPhase 2Terminated2023-02-21Actual
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract MalignanciesNCT05329766RCUSPhase 2Active not recruiting2027-01Estimated
A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)NCT05335122OCULPhase 2Completed2024-01-24Actual
RNS System LGS Feasibility StudyNCT05339126NeuroPacePhase 2Active not recruiting2026-11-30Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.